McLaughlin Gerald W. 4
4 · AYTU BIOPHARMA, INC · Filed Apr 12, 2021
Insider Transaction Report
Form 4
McLaughlin Gerald W.
Director
Transactions
- Award
Common Stock
2021-04-08+6,500→ 31,401 total
Footnotes (1)
- [F1]Grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of AYTU common stock. The RSUs have the following accelerated vesting conditions: (1) The consummation of a Sale Event. (2) The closing price of the Company's stock price is equal or greater than forty dollars per share ($40) for two consecutive trading days. (3) The Grantee's service with the Company or a Related Entity is terminated by the Company without Cause (as defined below).The RSUs vest as follows, and have no voting or dispositive rights until vested: one year vest from date of grant, April 8, 2021 such that the RSUs will be fully vested on April 8, 2022, subject to the reporting person's continuing employment with the Issuer.